Youssefyehet al (1992) Development of high-affinity 5-HT3
receptor antagonists. 1. Initial structure-activity relationship of novel
benzamides. J.Med.Chem. 35 895. Yeet al (2001)
Ondansetron: a selective 5-HT3 receptor antagonist and its
applications in CNS-related disorders. CNS Drug Rev. 7 199. Ginawi
et al (2005) Ondansetron, a selective antagonist, antagonizes
methamphetamine-induced anorexia in mice. Pharmacol.Res. 51 255.
Selective 5-HT7 receptor antagonist that displays > 100-fold selectivity over a range of other receptors. Reverses the hypothermic effect of 5-CT in mice following i.p. administration.